Schiff Says Glucosamine Class Can't Flake On $5M Deal
By Sindhu Sundar ( February 24, 2015, 9:30 PM EST) -- Schiff Nutrition International Inc. on Monday urged a California federal judge not to let plaintiffs back out on a $5 million class settlement over claims that it falsely marketed a glucosamine dietary supplement as an arthritis treatment, arguing that the Seventh Circuit's criticism of a different settlement over a similar product doesn't apply to this case. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.